Works matching IS 15228517 AND DT 2024 AND VI 26 AND IP 7
Results: 16
Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1280, doi. 10.1093/neuonc/noae068
- By:
- Publication type:
- Article
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1213, doi. 10.1093/neuonc/noae033
- By:
- Publication type:
- Article
Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric study.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1292, doi. 10.1093/neuonc/noae029
- By:
- Publication type:
- Article
Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1247, doi. 10.1093/neuonc/noae028
- By:
- Publication type:
- Article
A triad between sex, necrosis, and inflammation shapes glioblastoma outcomes.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1228, doi. 10.1093/neuonc/noae086
- By:
- Publication type:
- Article
Optic pathway gliomas: Long-term outcomes and challenges.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1325, doi. 10.1093/neuonc/noae079
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1352, doi. 10.1093/neuonc/noae084
- Publication type:
- Article
Locoregional delivery of chimeric antigen receptor-T cells: Breaking the spell in glioblastoma?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43<sub>266–283</sub> antitumor response in preclinical glioblastoma models.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1230, doi. 10.1093/neuonc/noae060
- By:
- Publication type:
- Article
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1181, doi. 10.1093/neuonc/noae049
- By:
- Publication type:
- Article
Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1327, doi. 10.1093/neuonc/noae048
- By:
- Publication type:
- Article
Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1310, doi. 10.1093/neuonc/noae045
- By:
- Publication type:
- Article
Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1195, doi. 10.1093/neuonc/noae041
- By:
- Publication type:
- Article
Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunities.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1335, doi. 10.1093/neuonc/noae038
- By:
- Publication type:
- Article
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1302, doi. 10.1093/neuonc/noae037
- By:
- Publication type:
- Article
Secreted clusterin inhibits tumorigenesis by modulating tumor cells and macrophages in human meningioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1262, doi. 10.1093/neuonc/noae034
- By:
- Publication type:
- Article